The interpretive variability of cervical biopsies and its relationship to HPV status

Mark H. Stoler, Brigitte M. Ronnett, Nancy E. Joste, William C. Hunt, Jack Cuzick, Cosette M. Wheeler, Walter Kinney, Alan Waxman, David Espey, Jane McGrath, Steven Jenison, Mark Schiffman, Philip E. Castle, Vicki Benard, Debbie Saslow, Jane J. Kim, Giovanna Rossi Pressley, Kevin English

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Diagnostic interpretation of a cervical biopsy is a key element in the decision to treat or not to treat a woman with an abnormal screening test. This study assesses the variability of these diagnostic interpretations on a population basis using the New Mexico HPV Pap Registry database. An experienced panel of gynecologic pathologists reviewed a stratified random sample of 6272 biopsies, which was then extrapolated to the entire population of 21,297 biopsies read by the community pathologists. Diagnoses by the community and panel pathologists were compared, and paired diagnoses were correlated with positivity for human papillomavirus 16 (HPV16) and any high-risk HPV as objective measures of progressive potential. Panel agreement with the community diagnosis was 38.2% for cervical intraepithelial neoplasia grade 1 (CIN1), 38.0% for CIN grade 2 (CIN2), 68.0% for CIN grade 3 (CIN3), and 70.6% for cancer. The κ value was 0.46 overall but higher for dichotomous categorization based on CIN2 or CIN3 cutoff points (0.68 and 0.67, respectively). On a population basis, there were fewer CIN1 and more negative diagnoses in the panel review but similar proportions of CIN2 and CIN3. HPV16 and high-risk HPV positivity increased with disease severity, but panel review did not improve the correlation of higher-grade disease with these objective measures. In this population-based study of the variability in cervical diagnoses, we noted significant variability in the community and panel diagnoses, especially for CIN2, the threshold for excisional treatment. New biomarkers are needed to more accurately stratify precursor lesions according to their malignant potential.

Original languageEnglish (US)
Pages (from-to)729-736
Number of pages8
JournalAmerican Journal of Surgical Pathology
Volume39
Issue number6
DOIs
StatePublished - May 26 2015
Externally publishedYes

Fingerprint

Biopsy
Cervical Intraepithelial Neoplasia
Human papillomavirus 16
Population
Registries
Biomarkers
Databases
Pathologists
Neoplasms
Therapeutics

Keywords

  • cervical cancer
  • cervical intraepithelial neoplasia grade 1 2 3
  • community and expert pathology panel diagnoses
  • histopathology diagnostic variability
  • human papillomavirus prevalence
  • United States

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery
  • Medicine(all)

Cite this

Stoler, M. H., Ronnett, B. M., Joste, N. E., Hunt, W. C., Cuzick, J., Wheeler, C. M., ... English, K. (2015). The interpretive variability of cervical biopsies and its relationship to HPV status. American Journal of Surgical Pathology, 39(6), 729-736. https://doi.org/10.1097/PAS.0000000000000381

The interpretive variability of cervical biopsies and its relationship to HPV status. / Stoler, Mark H.; Ronnett, Brigitte M.; Joste, Nancy E.; Hunt, William C.; Cuzick, Jack; Wheeler, Cosette M.; Kinney, Walter; Waxman, Alan; Espey, David; McGrath, Jane; Jenison, Steven; Schiffman, Mark; Castle, Philip E.; Benard, Vicki; Saslow, Debbie; Kim, Jane J.; Pressley, Giovanna Rossi; English, Kevin.

In: American Journal of Surgical Pathology, Vol. 39, No. 6, 26.05.2015, p. 729-736.

Research output: Contribution to journalArticle

Stoler, MH, Ronnett, BM, Joste, NE, Hunt, WC, Cuzick, J, Wheeler, CM, Kinney, W, Waxman, A, Espey, D, McGrath, J, Jenison, S, Schiffman, M, Castle, PE, Benard, V, Saslow, D, Kim, JJ, Pressley, GR & English, K 2015, 'The interpretive variability of cervical biopsies and its relationship to HPV status', American Journal of Surgical Pathology, vol. 39, no. 6, pp. 729-736. https://doi.org/10.1097/PAS.0000000000000381
Stoler, Mark H. ; Ronnett, Brigitte M. ; Joste, Nancy E. ; Hunt, William C. ; Cuzick, Jack ; Wheeler, Cosette M. ; Kinney, Walter ; Waxman, Alan ; Espey, David ; McGrath, Jane ; Jenison, Steven ; Schiffman, Mark ; Castle, Philip E. ; Benard, Vicki ; Saslow, Debbie ; Kim, Jane J. ; Pressley, Giovanna Rossi ; English, Kevin. / The interpretive variability of cervical biopsies and its relationship to HPV status. In: American Journal of Surgical Pathology. 2015 ; Vol. 39, No. 6. pp. 729-736.
@article{f9c174f0e0b449e0a52b51a345426cea,
title = "The interpretive variability of cervical biopsies and its relationship to HPV status",
abstract = "Diagnostic interpretation of a cervical biopsy is a key element in the decision to treat or not to treat a woman with an abnormal screening test. This study assesses the variability of these diagnostic interpretations on a population basis using the New Mexico HPV Pap Registry database. An experienced panel of gynecologic pathologists reviewed a stratified random sample of 6272 biopsies, which was then extrapolated to the entire population of 21,297 biopsies read by the community pathologists. Diagnoses by the community and panel pathologists were compared, and paired diagnoses were correlated with positivity for human papillomavirus 16 (HPV16) and any high-risk HPV as objective measures of progressive potential. Panel agreement with the community diagnosis was 38.2{\%} for cervical intraepithelial neoplasia grade 1 (CIN1), 38.0{\%} for CIN grade 2 (CIN2), 68.0{\%} for CIN grade 3 (CIN3), and 70.6{\%} for cancer. The κ value was 0.46 overall but higher for dichotomous categorization based on CIN2 or CIN3 cutoff points (0.68 and 0.67, respectively). On a population basis, there were fewer CIN1 and more negative diagnoses in the panel review but similar proportions of CIN2 and CIN3. HPV16 and high-risk HPV positivity increased with disease severity, but panel review did not improve the correlation of higher-grade disease with these objective measures. In this population-based study of the variability in cervical diagnoses, we noted significant variability in the community and panel diagnoses, especially for CIN2, the threshold for excisional treatment. New biomarkers are needed to more accurately stratify precursor lesions according to their malignant potential.",
keywords = "cervical cancer, cervical intraepithelial neoplasia grade 1 2 3, community and expert pathology panel diagnoses, histopathology diagnostic variability, human papillomavirus prevalence, United States",
author = "Stoler, {Mark H.} and Ronnett, {Brigitte M.} and Joste, {Nancy E.} and Hunt, {William C.} and Jack Cuzick and Wheeler, {Cosette M.} and Walter Kinney and Alan Waxman and David Espey and Jane McGrath and Steven Jenison and Mark Schiffman and Castle, {Philip E.} and Vicki Benard and Debbie Saslow and Kim, {Jane J.} and Pressley, {Giovanna Rossi} and Kevin English",
year = "2015",
month = "5",
day = "26",
doi = "10.1097/PAS.0000000000000381",
language = "English (US)",
volume = "39",
pages = "729--736",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The interpretive variability of cervical biopsies and its relationship to HPV status

AU - Stoler, Mark H.

AU - Ronnett, Brigitte M.

AU - Joste, Nancy E.

AU - Hunt, William C.

AU - Cuzick, Jack

AU - Wheeler, Cosette M.

AU - Kinney, Walter

AU - Waxman, Alan

AU - Espey, David

AU - McGrath, Jane

AU - Jenison, Steven

AU - Schiffman, Mark

AU - Castle, Philip E.

AU - Benard, Vicki

AU - Saslow, Debbie

AU - Kim, Jane J.

AU - Pressley, Giovanna Rossi

AU - English, Kevin

PY - 2015/5/26

Y1 - 2015/5/26

N2 - Diagnostic interpretation of a cervical biopsy is a key element in the decision to treat or not to treat a woman with an abnormal screening test. This study assesses the variability of these diagnostic interpretations on a population basis using the New Mexico HPV Pap Registry database. An experienced panel of gynecologic pathologists reviewed a stratified random sample of 6272 biopsies, which was then extrapolated to the entire population of 21,297 biopsies read by the community pathologists. Diagnoses by the community and panel pathologists were compared, and paired diagnoses were correlated with positivity for human papillomavirus 16 (HPV16) and any high-risk HPV as objective measures of progressive potential. Panel agreement with the community diagnosis was 38.2% for cervical intraepithelial neoplasia grade 1 (CIN1), 38.0% for CIN grade 2 (CIN2), 68.0% for CIN grade 3 (CIN3), and 70.6% for cancer. The κ value was 0.46 overall but higher for dichotomous categorization based on CIN2 or CIN3 cutoff points (0.68 and 0.67, respectively). On a population basis, there were fewer CIN1 and more negative diagnoses in the panel review but similar proportions of CIN2 and CIN3. HPV16 and high-risk HPV positivity increased with disease severity, but panel review did not improve the correlation of higher-grade disease with these objective measures. In this population-based study of the variability in cervical diagnoses, we noted significant variability in the community and panel diagnoses, especially for CIN2, the threshold for excisional treatment. New biomarkers are needed to more accurately stratify precursor lesions according to their malignant potential.

AB - Diagnostic interpretation of a cervical biopsy is a key element in the decision to treat or not to treat a woman with an abnormal screening test. This study assesses the variability of these diagnostic interpretations on a population basis using the New Mexico HPV Pap Registry database. An experienced panel of gynecologic pathologists reviewed a stratified random sample of 6272 biopsies, which was then extrapolated to the entire population of 21,297 biopsies read by the community pathologists. Diagnoses by the community and panel pathologists were compared, and paired diagnoses were correlated with positivity for human papillomavirus 16 (HPV16) and any high-risk HPV as objective measures of progressive potential. Panel agreement with the community diagnosis was 38.2% for cervical intraepithelial neoplasia grade 1 (CIN1), 38.0% for CIN grade 2 (CIN2), 68.0% for CIN grade 3 (CIN3), and 70.6% for cancer. The κ value was 0.46 overall but higher for dichotomous categorization based on CIN2 or CIN3 cutoff points (0.68 and 0.67, respectively). On a population basis, there were fewer CIN1 and more negative diagnoses in the panel review but similar proportions of CIN2 and CIN3. HPV16 and high-risk HPV positivity increased with disease severity, but panel review did not improve the correlation of higher-grade disease with these objective measures. In this population-based study of the variability in cervical diagnoses, we noted significant variability in the community and panel diagnoses, especially for CIN2, the threshold for excisional treatment. New biomarkers are needed to more accurately stratify precursor lesions according to their malignant potential.

KW - cervical cancer

KW - cervical intraepithelial neoplasia grade 1 2 3

KW - community and expert pathology panel diagnoses

KW - histopathology diagnostic variability

KW - human papillomavirus prevalence

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=84929950916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929950916&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000381

DO - 10.1097/PAS.0000000000000381

M3 - Article

C2 - 25602796

AN - SCOPUS:84929950916

VL - 39

SP - 729

EP - 736

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 6

ER -